insights_auto
Why is SABS down 2,67%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,92 $
arrow_downward
-2,67%(-0,080) 1D
17 նոյ, 13:01:52 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,01 $
High
3,03 $
Low
2,92 $
Mkt. cap
263,06 մլն
Avg. vol.
692,36 հզր
Volume
108,46 հզր
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 մլն
No. of employees
86
Open
3,01 $
High
3,03 $
Low
2,92 $
Mkt. cap
263,06 մլն
Avg. vol.
692,36 հզր
Volume
108,46 հզր
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 մլն
No. of employees
86
News stories
From web sources and news partners
Investing.com
·
8 ժամ առաջ
SAB Biotherapeutics at UBS conference: late-stage diabetes bet
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersՄայամի Բիչ, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitesab.bio